Abstract 461: Antiphospholipid Antibodies In Covid-19 Convalescent Plasma
Wyatt Becicka, Yogendra Kanthi(National Heart Lung and Blood Institute), Gil Berreby, Philip J. Norris(University of California, San Francisco), Yu Zouo(University of Michigan), Sumith R. Panicker(Unknown), Larry J. Dumont(Dartmouth College), Jason S. Knight(University of Michigan), Jaideep Moitra, Benjamin E. Tourdot(Cincinnati Children's Hospital Medical Center), Jintao Wang(Second Affiliated Hospital of Jilin University), Kathleen Kelly(Vitalant)
Cited by 0
Related Papers
Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis
|Circulation Research|2014|444
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
|Science Translational Medicine|2021|237
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
|Science Translational Medicine|2011|183
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
|Science Advances|2021|150